{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":1320,"summary":"Hosted by Corey with the Story. Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe! The Daily News Now! — Every city. Every story. AI-powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T18:18:57.837082+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Eli Lilly’s Vaccine Bet for the Future","slug":"eli-lilly-s-vaccine-bet-for-the-future","published_at":"2026-06-06T19:52:35+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/eli-lilly-s-vaccine-bet-for-the-future","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/0d6d2132-03a6-45b8-ab9c-feef1a6baba0.mp3","audio_url":"https://api.fastcast.ai/audio/0d6d2132-03a6-45b8-ab9c-feef1a6baba0.mp3","summary":"Eli Lilly just splashed three point eight billion on vaccine companies, quietly shifting gears from its cash-gushing GLP-1 drugs like Mounjaro and Zepbound. While investors fixate on those blockbuster earners, this move is a strategic long-term play to diversify into infectious disease territory — a smart hedge against patent expiration and revenue slowdowns. It’s not flashy now, but it’s a calculated step toward building a more resilient, future-proof pharmaceutical powerhouse. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/374eb1ddc06eaab0","meta_description":"Eli Lilly just splashed three point eight billion on vaccine companies, quietly shifting gears from its cash-gushing GLP-1 drugs like Mounjaro and Zepboun…","key_points":[],"chapters":[],"topics":[],"duration_seconds":98,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/eli-lilly-s-vaccine-bet-for-the-future/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/eli-lilly-s-vaccine-bet-for-the-future.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}